Biopharamceuticals

PerkinElmer has launched the Cellaca PLX Image Cytometry System, a first-of-its-kind benchtop platform that enables researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow, including cell identity, quality and quantity.  The system, designed by the company’s Nexcelom unit, combines best-in-class image cytometer hardware, software, validated consumables and trackable […]

Beckman Coulter Life Sciences has released a call for registrations for its SPRI Grants for Genomic Research, which the company describes as part of its commitment to the next generation of researchers and scientists.  Reinforcing its dedication to providing streamlined genomic workflow solutions, the company will award up to eight grants in 2022. The grants […]

A new In Vitro Pharmacology Working Group to accelerate regulatory submissions has been created by the Pistoia Alliance, a global advocate for greater collaboration in life sciences R&D. The group will include liaisons from the US Food and Drug Administration’s Center for Drug Evaluation and Research, as well as representatives from biopharmaceutical companies, contract research […]

Conventional bioassays rely on enzyme or fluorescent labels to detect biomolecular interactions. These come with challenges that lead to skewed and inaccurate results. In this eBook, learn how label-free interaction techniques drive: Faster analysis – fewer sample preparation steps More sensitive analysis – enabling close observation of small and fragment molecules and proteins in complex matrices […]

DDW Editor Reece Armstrong looks at the cell and gene therapy landscape, examining the challenges facing developers and the trends we can expect to see throughout the year.   There’s no doubt that cell and gene therapies present some of the most exciting opportunities for emerging drugs. This area of medicine, which turns our own bodies into […]

Susan A Darling, Senior Director, CE and Biopharma, SCIEX and Todd Stawicki, Senior Global Marketing Manager, Biopharma, SCIEX examine advanced analytical technologies can help ensure that biopharma candidates are commercialisable. Developability in the biopharmaceutical industry relates to the difficulty of making early candidate molecules with attractive biological activities into commercialised and marketable therapies. The ‘developability […]

By Sabrina Gérard, Head of Sustainability and Agility at Datwyler The global pharmaceutical industry has long had to triage priorities to deliver for its customers and society at large. Developing and delivering new therapeutics is time-and energy-intensive, and the pandemic has starkly highlighted the challenges the world faces with supply chains and drug delivery systems.   […]

From AI to 3D deep-learning research to biologics, Lu Rahman selects some interesting global start-ups pushing the boundaries in drug discovery. Owkin French-American startup, Owkin is focussed on using artificial intelligence (AI) to discover and develop better treatments for unmet medical needs, starting with the fight against cancer. Using AI, the company identifies new drug […]

GSK will acquire clinical-stage biopharmaceutical company Affinivax in a deal potentially worth over $3 billion.  GSK will acquire Affinivax for an upfront payment of $2.1 billion and is offering up to $1.2 billion in potential development milestones.   Affinivax is developing a novel class of vaccines, its most advanced of which is focused on pneumococcal diseases. […]

DDW Deputy Editor Reece Armstrong looks at the key points of GSK’s first quarter earnings.   UK pharmaceutical company GSK has reported strong financial earnings for the first quarter of 2022.  The pharma giant reported total sales in Q1 of £9.8 billion, crediting much of that to the company’s biopharma offerings.  In a breakdown of GSK’s […]